Pharmacokinetic analysis of α and β epimers of glycyrrhetinic acid in rat plasma: Differences in singly and combined administrations

Yaoxue Xuebao

Volumn 47, Issue 1, 2012, Pages 94-100

  Sun, Hao Yang ^a   Li, Qing ^a   Chen, Wei ^b   Geng, Lu Lu ^a   Li, Xi ^a   Chen, Xiao Hui ^a   Bi, Kai Shun ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b Panshi City Hospital of Jilin Province   (China)

Author keywords

Epimer; Glycyrrhetinic acid; HPLC; Pharmacokinetics

Indexed keywords

18ALPHA GLYCYRRHETINIC ACID; ACETONITRILE; AMMONIUM ACETATE; GLYCYRRHETINIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; EPIMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; NONHUMAN; RAT;

ANIMALS; AREA UNDER CURVE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLYCYRRHETINIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY; STEREOISOMERISM;

EID: 84862956526     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jin M, Wu HJ. Advancement on pharmacological action of glycyrrhetinic acid [J]. Med Recapit 2009,15:1712-1715.
2. Hao F. Advances in the foreign research of glycyrrhetinic acid[J]. China Pharm 2001,12:500-501.
3. Takeda S, Ishihara K, Wakui Y, et al. Bioavailability study of glycyrrhetinic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis [J]. J Pharm Pharmacol, 1996,48:902-905. (Pubitemid 26364890)
4. Van Rossum TG, Vulto AG, De Man RA, et al. Glycyrrhizin as a potential treatment for chronic hepatitis C [J]. Aliment Pharmacol ther, 1998,12:199-205. (Pubitemid 28160013)
5. Ohuchi K, Kamada Y, Levine L, et al. Glycyrrhizin inhibits prostaglandin E2 production by activated peritoneal macrophages from rats [J]. Prostaglandins Med, 1981,7:457-463. (Pubitemid 12249608)
6. Ito M, Sato A, Hirabayashi K, et al. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV) [J]. Antiviral Res, 1988,10:289-298. (Pubitemid 19073538)
7. Abe N, Ebina T, Ishida N. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice [J]. Microbiol Immunol, 1982,26:535-539. (Pubitemid 12068620)
8. Kiso Y, Tohkin M, Hikino H, et al. Mechanism of antihepatotoxic activity of glycyrrhizin, I: Effect of free radical generation and lipid peroxidation [J]. Planta Med, 1984,50:298-302. (Pubitemid 14008705)
9. Shibayama Y. Prevention of hepatotoxic responses to chemicals by glycyrrhizin in rats [J]. Exp Mol Pathol, 1989,51:48-55. (Pubitemid 19228271)
10. Nose M, Ito M, Kamimira K, et al. A comparison of the antihepatotoxic activity between glycyrrhizin and glycyrrhetinic acid [J]. Planta Med, 1994,60:136-139. (Pubitemid 24120897)
11. Horigome H, Hirano T, Oka K. Therapeutic effect of glycyrrhetinic acid in MRL lpr/lpr mice: implications of alteration of corticosteroid metabolism [J]. Life Sci, 2001,69:2429-2438. (Pubitemid 32971971)
12. Armanini D, De Palo CB, Mattarello MJ, et al. Effect of licorice on the reduction of body fat mass in healthy subjects [J]. J Endocrinol Invest, 2003,26:646-650. (Pubitemid 37270696)
13. Zhang QF, Chen XH, Yi LX, et al. Pharmacokinetics of 2 epimers of glycyrrhizic in rats [J]. Cent South Pharm 2010,8:350-354.
14. Lindner W, Rath M, Stoschitzky K, et al. Pharmacokinetic data of propranolol enantiomers in a comparative human study with (S)- and (R, 5)-propranolol [J]. Chirality, 1989,1:10-13. (Pubitemid 19187331)
15. Chen H, Liu H, Yin XQ, et al. Chemical and bioactivity of glycyrrhizic acid [J]. Zhejiang J Integr Tradit Chin West Med 2007,17:130-135.
16. Wu XM, Lv J, Ru RP. Comparison research of 18H epimeric glycyrrhizic acids [J]. Chin Pharm J (), 1993,28:215-218.
17. Wu XM, Lv J, Li BR, et al. Therapeutic effects of epimeric glycyrrhizic acids on hepatic injury in rats [J]. Acta Pharmacol Sin, 1992,13:370-374.
18. Xu HX. Adverse drug reactions of glycyrrhizic acids [J]. Adverse Drug React J 2003,5:166-171.
19. Yu ZS, Sang YX. A report of glycyrrhizin caused the sodium and water retention [J]. Chin J Pharmacoepidemiol 2001,2:228-231.
20. Tao CX. Medicinal research of glycyrrhizic acid [J]. Chin J Pract Chin Mod Med 2004,15:2285-2288.
21. Yan M, Li LF, Li HD. A review of comparison of glycyrrhizic acid and glycyrrhetinic acid [J]. Tradit Chin Drug Res Clin Pharmacol 2010,5:562-566.
22. Zou QG, Wei P, Li J, et al. Simultaneous determination of 18α- and 18β-glycyrrhetic acid in human plasma by LC-ESI-MS and its application to pharmacokinetics [J]. Biomed Chromatogr, 2009,23:54-62.
23. Lu Y, Li J, Du SY. Study on pharmacokinetics of glycyrrhetinic acid in rats by RP-HPLC [J]. China J Chin Mater Med 2008,33:1294-1296.
24. Li L, Jin YT, Qiu RL. Advancement and application in the research of glycyrrhizic acid [J]. Anti Infect Pharm 2004,1:103-106.